Viewing Study NCT01288092


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2025-12-30 @ 12:18 AM
Study NCT ID: NCT01288092
Status: WITHDRAWN
Last Update Posted: 2012-06-07
First Post: 2011-01-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module